Protection and mechanism of dexmedetomidine preconditioning against neuronal injury related to oxygen-glucose deprivation

LI Gong-Yang, ZHANG Jian-Xing, WANG Xing, XU Wei, ZHOU Guo-Bin

Chinese Journal of Clinical Anatomy ›› 2014, Vol. 32 ›› Issue (4) : 455-457.

Chinese Journal of Clinical Anatomy ›› 2014, Vol. 32 ›› Issue (4) : 455-457. DOI: 10.13418/j.issn.1001-165x.2014.04.020

Protection and mechanism of dexmedetomidine preconditioning against neuronal injury related to oxygen-glucose deprivation

  • LI Hong-ying, ZHANG Jian-xing, WANG Yan, YU Wei,  ZHOU Guo-bin
Author information +
History +

Abstract

Objective To study the protection and mechanism of dexmedetomidine preconditioning against neuronal injury related to oxygen–glucose deprivation(OGD). Methods Cortical neurons from the embryonic day 16~18 rats were cultured. With mimicking a cerebral ischemia in vitro, OGD was performed in the pretreated cells. Neuron injury was assessed by MTT. Protein expression of p-p38 was examined by Western blot. Results Dexmedetomidine preconditioning protected the dose-dependent cortical neurons from OGD injury. Conclusions Dexmedetomidine preconditioning protects the cortical neuron from OGD injury; inhibition of p38MAPK pathway maybe one of the mechanisms responsible for this effect.

Key words

Dexmedetomidine / Oxygen-glucose deprivation / Cortical neurons / Rats

Cite this article

Download Citations
LI Gong-Yang, ZHANG Jian-Xing, WANG Xing, XU Wei, ZHOU Guo-Bin. Protection and mechanism of dexmedetomidine preconditioning against neuronal injury related to oxygen-glucose deprivation[J]. Chinese Journal of Clinical Anatomy. 2014, 32(4): 455-457 https://doi.org/10.13418/j.issn.1001-165x.2014.04.020

References


[1] Jalowiecki P, Rudner R, Gonciarz M, et al. Sole use of dexmedetomidine has limited utility for conscious sedation during outpatient colonoscopy
[J].Anesthesiology, 2005,103(2):269-273.

[2] Chiu KM,Lin TY,Lu CW,et al.Inhibitory effect of glutamate release from rat cerebrocortical nerve terminals by a2 adrenoceptor agonist dexmedetomidine
[J] .Eur J Pharmacol,2011,670(1):137-147.

[3] Dahmani S, Rouelle D, Gressens P ,et al. Effects of dexmedetomidine on hippocampal focal adhesion kinase tyrosine phosphorylation in physiologic and ischemic conditions
[J].Anesthesiology,2005, l03(5):969-977

[4] Xia Z, Dickens M, Raingeaud J, et al. Opposing effects of ERK and JNK-p38 MAP kinases on apoptosis
[J]. Science, 1995, 270 (240):1326-1331.

[5] DPvies SP, Reddy H, Caivano M, et al. Specificity and mechanism of action of some commonly used protein kinase inhibitors
[J]. Biochem J, 2000, 351(1):95-105.

[6] Torocsik B, Szeberenyi J. Anisomycin uses multiple mechanisms to stimulate mitogen-activated protein kinases and gene expression and to inhibit neuronal differentiation in PC12 phaeochro- mocytoma cells
[J]. Eur J Neurosci,2000,12 (2):527-532.

[7] 莫利求,兰爱平,林琳,等.右美托咪定对抗化学性低氧引起的PCl2细胞损伤
[J].中国药理学通报,20ll,27(9):l288-l292.

Accesses

Citation

Detail

Sections
Recommended

/